Marija Mojicevic

Mar 2, 2024 | mdpi.com | Marija Mojicevic |Eduardo Garcia |Eduardo García |Margaret Brennan Fournet |Cuneyt Erdinc Tas

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Dec 3, 2023 | mdpi.com | Marija Mojicevic |Brana Pantelic |Akanksha Joshi |Catherine Collins

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Jul 26, 2023 | mdpi.com | Eduardo Garcia |Eduardo García |Marija Mojicevic |Miriam Huerta |Buket Alkan Tas

3. DiscussionFibronectin (Fn), a critical ECM protein whose functions are governed by its conformational activity, is receiving increasing attention due to its participation in various phases of tumor proliferation and other complications of medical importance such as Fn glomerulopathy [25,26,27]. In this study, the suitability of PEGAuTSNPs for use as platforms for IAs was successfully demonstrated.